<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046015"><TermName>exisulind</TermName><TermPronunciation>(ek-sih-SOO-lind)</TermPronunciation><TermDefinition><DefinitionText>A drug being studied in the treatment and prevention of cancer. It has been shown to cause apoptosis (cell death) in cells that are malignant (cancer) and in cells that may become cancer. It acts through a group of cellular enzymes called cGMP phosphodiesterases.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000707590" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exisulind&quot;" language="en" id="_3"/><MediaLink ref="CDR0000707589" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exisulind&quot;" language="es" id="_4"/><SpanishTermName>exisulind</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento en estudio para la prevención y el tratamiento de cáncer. Ha demostrado que produce la apoptosis (muerte celular) de células malignas (cancerosas) y de células que se pueden convertir en cáncer. Actúa a través de un grupo de enzimas celulares que se llaman fosfodiesterasas cGMP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2009-06-18</DateLastModified></GlossaryTerm>
